Taka
US Dollar
Product Description
Semaglutide is a synthetic GLP-1 receptor agonist designed for advanced metabolic regulation, weight management, and glucose control. It mimics the action of endogenous glucagon-like peptide-1 (GLP-1), a hormone that enhances insulin secretion, suppresses glucagon release, and slows gastric emptying in a glucose-dependent manner.
Semaglutide has demonstrated significant potential in studies related to obesity, type 2 diabetes, and cardiovascular risk reduction, making it one of the most widely known incretin mimetics in modern metabolic science.
